
Specialties
Biography
Dr. Ellisen is a practicing oncologist and researcher at the Massachusetts General Hospital Cancer Center, an Associate Professor of Medicine at Harvard Medical School, and co-Executive Director of the Cancer Center's Translational Research Laboratory (TRL). He received his undergraduate degree from Harvard University, MD and PhD degrees from Stanford University, and completed residency training, oncology fellowship training, and postdoctoral research training at Brigham and Women's Hospital, the Dana-Farber Cancer Institute, and Mass General, respectively. Dr. Ellisen is widely published in the field of cancer biology and cancer genetics. His basic research efforts focus on chemosensitivity in breast and other cancers. His work in the TRL focuses on the clinical application of tumor genetic testing to advance the goal of personalized medicine. He serves on numerous grant review committees and editorial boards, and his work on personalized cancer medicine has been featured in the news media including the Wall Street Journal and the ABC Evening News.
Research
Publications
The Massachusetts General Hospital Cancer Center is committed to advancing oncology care by tailoring treatment options to the individual cancer patient. The basic mission of the Translational Research Laboratory (TRL) is to provide rapid personalized genomic testing as an important component of routine care, thereby minimizing generalizations made in treatment decisions.
Phone: 617-726-6500
Phone: 978-287-3436
Fax: 978-287-3642